Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245763 · ClinicalTrials.gov registry record
STS/ACC TVT Registry Mitral Module
A clinical trial of Mitral Valve Regurgitation, sponsored by American College of Cardiology.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT02245763 is a study of Mitral Valve Regurgitation that is actively recruiting participants, run by American College of Cardiology. The registered enrollment target is 4,000 participants, above the 451-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (787% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02245763, a study of Mitral Valve Regurgitation, is actively recruiting participants, sponsored by American College of Cardiology.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of mitral valve disease.
Conditions Studied
Interventions
- DEVICE Leaflet Clip
Study Locations (1)
District of Columbia
- American College of Cardiology - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2013-11 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02245763
The ClinicalTrials.gov registry entry for NCT02245763 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 451-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (787% higher). The listed sponsor is American College of Cardiology, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mitral Valve Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Leaflet Clip is the first listed.
NCT02245763 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02245763 about?
NCT02245763 is a clinical study titled "STS/ACC TVT Registry Mitral Module". The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monito...
What is the current status of trial NCT02245763?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2013-11. Estimated completion is 2030-12-31.
What conditions does trial NCT02245763 study?
This clinical trial studies the following conditions: Mitral Valve Regurgitation.
What interventions are being tested in trial NCT02245763?
The interventions under investigation include: Leaflet Clip (DEVICE).
Who is sponsoring clinical trial NCT02245763?
This trial is sponsored by American College of Cardiology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02245763 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
RECRUITING · NA
-
AltaValve Pivotal Trial
RECRUITING · NA
-
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
RECRUITING · NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
ACTIVE NOT RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
-
MitraClip REPAIR MR Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.